Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Polycystic Ovary Syndrome 7Obesity 5Weight Loss 2Infertility, Female 2Infertility 2Sexual Infantilism 1Prediabetic State 1Pancreatic Neoplasms 1Obesity, Abdominal 1Metabolic Syndrome 1Insulin Resistance 1Inflammation 1Glucose Intolerance 1Dyslipidemias 1Diabetes Mellitus, Type 2 1Craniopharyngioma 1Combined Pituitary Hormone Deficiency 1Cardiovascular Diseases 1

Interventions

Surgical Procedures, Operative 3Exenatide 3tocilizumab 2Surveys and Questionnaires 2Radiotherapy 2Proton Therapy 2Mental Status and Dementia Tests 2Magnetic Resonance Spectroscopy 2Donepezil 2trametinib 1tozuleristide 1tovorafenib 1temsirolimus 1gallium Ga 68 dotatate 1dabrafenib 1cobimetinib 1binimetinib 1antineoplaston AS 2-1 1antineoplaston A10 1anlotinib 1Vemurafenib 1Tumor Burden 1Transurethral Resection of Bladder 1Thalidomide 1Temozolomide 1Radiotherapy, Image-Guided 1Radiation 1Qsymia 1Prednisone 1Photochemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Craniopharyngioma × Liraglutide × Clear all
NCT06217848 2024-01-23

The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study

Seoul National University Hospital

Phase EARLY_PHASE1 Unknown
50 enrolled
CNSEndocrine

Combined Pituitary Hormone Deficiency, Craniopharyngioma, Sexual Infantilism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡